Effect of naringerin on biochemical parameters in the streptozotocin-induced diabetic rats

Amongst the numerous co-adjuvant therapies which could influence the incidence and progression of diabetic complications, antioxidants and flavonoids are currently being tested in clinical trials. We investigated the effect of naringerin on biochemical parameters in streptozotocin-induced (STZ - 60...

Full description

Bibliographic Details
Main Authors: Ana Angélica Henrique Fernandes, Ethel Lourenzi Barbosa Novelli, Ary Fernandes Junior, Cristiano Machado Galhardi
Format: Article
Language:English
Published: Instituto de Tecnologia do Paraná (Tecpar) 2009-02-01
Series:Brazilian Archives of Biology and Technology
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-89132009000100007
_version_ 1828161251193126912
author Ana Angélica Henrique Fernandes
Ethel Lourenzi Barbosa Novelli
Ary Fernandes Junior
Cristiano Machado Galhardi
author_facet Ana Angélica Henrique Fernandes
Ethel Lourenzi Barbosa Novelli
Ary Fernandes Junior
Cristiano Machado Galhardi
author_sort Ana Angélica Henrique Fernandes
collection DOAJ
description Amongst the numerous co-adjuvant therapies which could influence the incidence and progression of diabetic complications, antioxidants and flavonoids are currently being tested in clinical trials. We investigated the effect of naringerin on biochemical parameters in streptozotocin-induced (STZ - 60 mg/kg, i.p.) diabetic rats. Male rats were divided into four groups: G1: untreated controls; G2: normal rats receiving naringerin; G3: untreated diabetics; G4: diabetics rats receiving naringerin. The naringerin (50mg/kg, i.p,) decreased the hyperglycaemia and hyperlipidaemia associated with STZ-diabetes. The concentrations of serum insulin in treated diabetic rats tended to be increased. Naringerin treatment prevents STZ-induced changes in the activities of ALT, AST and LDH in the liver and heart, indicating the protective effect of naringerin against the hepatic and cardiac toxicity caused by STZ. The glycogen level in cardiac and hepatic tissues elevated with naringerin in diabetic rats. The naringerin can improve the glucose and lipid metabolism and is beneficial in preventing diabetic complications.<br>Dentre as numerosas terapias para minimizar as complicações diabéticas, os antioxidantes e flavonoides são testados na clínica médica. Foi analisado o efeito da naringerina sobre os parâmetros bioquímicos em ratos diabéticos induzidos por estreptozotocina (STZ - 60mg/kg, i.p.). Ratos machos foram divididos em 4 grupos: G1: controle não tratado; G2: ratos normais que receberam naringerina; G3: diabéticos não tratados; G4: ratos diabéticos que receberam naringerina. Naringerina (50mg/kg, i.p.), decresceu a hiperglicemia e a hiperlipidemia em ratos diabéticos. A concentração sérica de insulina em ratos tratados tendeu aumentar. A naringerina preveniu as alterações, provocadas pela estreptozotocina, na atividade hepática e cardíaca de ALT, AST e LDH, indicando o efeito protetor da naringerina sobre estes tecidos, contra toxicidade provocada pela STZ. O nível de glicogênio nos tecidos cardíaco e hepático elevou com a naringerina em ratos diabéticos. A naringerina melhorou o metabolismo da glicose e de lipídios e preveniu as complicações diabéticas.
first_indexed 2024-04-12T00:35:30Z
format Article
id doaj.art-aa2e49bf31774367b524a6138b594b5b
institution Directory Open Access Journal
issn 1516-8913
1678-4324
language English
last_indexed 2024-04-12T00:35:30Z
publishDate 2009-02-01
publisher Instituto de Tecnologia do Paraná (Tecpar)
record_format Article
series Brazilian Archives of Biology and Technology
spelling doaj.art-aa2e49bf31774367b524a6138b594b5b2022-12-22T03:55:11ZengInstituto de Tecnologia do Paraná (Tecpar)Brazilian Archives of Biology and Technology1516-89131678-43242009-02-01521515910.1590/S1516-89132009000100007Effect of naringerin on biochemical parameters in the streptozotocin-induced diabetic ratsAna Angélica Henrique FernandesEthel Lourenzi Barbosa NovelliAry Fernandes JuniorCristiano Machado GalhardiAmongst the numerous co-adjuvant therapies which could influence the incidence and progression of diabetic complications, antioxidants and flavonoids are currently being tested in clinical trials. We investigated the effect of naringerin on biochemical parameters in streptozotocin-induced (STZ - 60 mg/kg, i.p.) diabetic rats. Male rats were divided into four groups: G1: untreated controls; G2: normal rats receiving naringerin; G3: untreated diabetics; G4: diabetics rats receiving naringerin. The naringerin (50mg/kg, i.p,) decreased the hyperglycaemia and hyperlipidaemia associated with STZ-diabetes. The concentrations of serum insulin in treated diabetic rats tended to be increased. Naringerin treatment prevents STZ-induced changes in the activities of ALT, AST and LDH in the liver and heart, indicating the protective effect of naringerin against the hepatic and cardiac toxicity caused by STZ. The glycogen level in cardiac and hepatic tissues elevated with naringerin in diabetic rats. The naringerin can improve the glucose and lipid metabolism and is beneficial in preventing diabetic complications.<br>Dentre as numerosas terapias para minimizar as complicações diabéticas, os antioxidantes e flavonoides são testados na clínica médica. Foi analisado o efeito da naringerina sobre os parâmetros bioquímicos em ratos diabéticos induzidos por estreptozotocina (STZ - 60mg/kg, i.p.). Ratos machos foram divididos em 4 grupos: G1: controle não tratado; G2: ratos normais que receberam naringerina; G3: diabéticos não tratados; G4: ratos diabéticos que receberam naringerina. Naringerina (50mg/kg, i.p.), decresceu a hiperglicemia e a hiperlipidemia em ratos diabéticos. A concentração sérica de insulina em ratos tratados tendeu aumentar. A naringerina preveniu as alterações, provocadas pela estreptozotocina, na atividade hepática e cardíaca de ALT, AST e LDH, indicando o efeito protetor da naringerina sobre estes tecidos, contra toxicidade provocada pela STZ. O nível de glicogênio nos tecidos cardíaco e hepático elevou com a naringerina em ratos diabéticos. A naringerina melhorou o metabolismo da glicose e de lipídios e preveniu as complicações diabéticas.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-89132009000100007Naringerinhypoglycaemic activitystreptozotocindiabetes mellitusaminotransferaseshepaticcardiac tissues
spellingShingle Ana Angélica Henrique Fernandes
Ethel Lourenzi Barbosa Novelli
Ary Fernandes Junior
Cristiano Machado Galhardi
Effect of naringerin on biochemical parameters in the streptozotocin-induced diabetic rats
Brazilian Archives of Biology and Technology
Naringerin
hypoglycaemic activity
streptozotocin
diabetes mellitus
aminotransferases
hepatic
cardiac tissues
title Effect of naringerin on biochemical parameters in the streptozotocin-induced diabetic rats
title_full Effect of naringerin on biochemical parameters in the streptozotocin-induced diabetic rats
title_fullStr Effect of naringerin on biochemical parameters in the streptozotocin-induced diabetic rats
title_full_unstemmed Effect of naringerin on biochemical parameters in the streptozotocin-induced diabetic rats
title_short Effect of naringerin on biochemical parameters in the streptozotocin-induced diabetic rats
title_sort effect of naringerin on biochemical parameters in the streptozotocin induced diabetic rats
topic Naringerin
hypoglycaemic activity
streptozotocin
diabetes mellitus
aminotransferases
hepatic
cardiac tissues
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-89132009000100007
work_keys_str_mv AT anaangelicahenriquefernandes effectofnaringerinonbiochemicalparametersinthestreptozotocininduceddiabeticrats
AT ethellourenzibarbosanovelli effectofnaringerinonbiochemicalparametersinthestreptozotocininduceddiabeticrats
AT aryfernandesjunior effectofnaringerinonbiochemicalparametersinthestreptozotocininduceddiabeticrats
AT cristianomachadogalhardi effectofnaringerinonbiochemicalparametersinthestreptozotocininduceddiabeticrats